Correction: Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells

Correction: Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells

Show other versions (1)

Bibliographic Details
Main Authors:	Sascha Venturelli, Alexander Berger, Alexander Böcker, Christian Busch, Timo Weiland, Seema Noor, Christian Leischner, Sabine Schleicher, Mascha Mayer, Thomas S. Weiss, Stephan C. Bischoff, Ulrich M. Lauer, Michael Bitzer
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765455/?tool=EBI

Similar Items

Correction: Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells.
by: Sascha Venturelli, et al.
Published: (2013-01-01)

Resveratrol as a pan-HDAC inhibitor alters the acetylation status of histone [corrected] proteins in human-derived hepatoblastoma cells.
by: Sascha Venturelli, et al.
Published: (2013-01-01)

Comparative Analysis of the Antitumor Activity of Cis- and Trans-Resveratrol in Human Cancer Cells with Different p53 Status
by: Christian Leischner, et al.
Published: (2021-09-01)

Protein Acetylation and the Physiological Role of HDACs
by: Patrick Matthias, et al.
Published: (2011-01-01)

6- and 8-Prenylnaringenin, Novel Natural Histone Deacetylase Inhibitors Found in Hops, Exert Antitumor Activity on Melanoma Cells
by: Sascha Venturelli, et al.
Published: (2018-11-01)

Hepatoblastoma
by: Raùl Pichardo-Bahena, et al.
Published: (2005-04-01)

Potential Protective Protein Components of Cow’s Milk against Certain Tumor Entities
by: Christian Leischner, et al.
Published: (2021-06-01)

Hepcidin is regulated by promoter-associated histone acetylation and HDAC3
by: Sant-Rayn Pasricha, et al.
Published: (2017-09-01)

Ex Vivo Evaluation of the Sepsis Triple Therapy High-Dose Vitamin C in Combination with Vitamin B1 and Hydrocortisone in a Human Peripheral Blood Mononuclear Cells (PBMCs) Model
by: Annie Lauer, et al.
Published: (2021-07-01)

Adult hepatoblastoma
by: Javier A. Cienfuegos, et al.

Hepatoblastoma—The Evolution of Biology, Surgery, and Transplantation
by: Irene Isabel P. Lim, et al.
Published: (2018-12-01)

Epigenetic impacts of ascorbate on human metastatic melanoma cells
by: Sascha eVenturelli, et al.
Published: (2014-08-01)

Physical and Functional HAT/HDAC Interplay Regulates Protein Acetylation Balance
by: Alessia Peserico, et al.
Published: (2011-01-01)

Evaluation of Resveratrol, Oxyresveratrol and Acetyl-Resveratrol stability in the Medium and Their Effect on the Lifespan of Hs68 cells
by: Chia-Wen Chen, et al.
Published: (2016)

The Genetic Changes of Hepatoblastoma
by: Huitong Chen, et al.
Published: (2021-07-01)

Hepatoblastoma: when to screen?
by: O’Malley Margaret, et al.
Published: (2011-03-01)

Hepatoblastoma with precocious puberty
by: Enono Yhoshu, et al.
Published: (2019-01-01)

Nɛ-acetyl lysine derivatives with zinc binding groups as novel HDAC inhibitors
by: Fang Wang, et al.
Published: (2019-06-01)

Pan-HDAC Inhibitors Promote Tau Aggregation by Increasing the Level of Acetylated Tau
by: Hyeanjeong Jeong, et al.
Published: (2019-09-01)

Resveratrol inhibits ACHN cells via regulation of histone acetylation
by: Lili Dai, et al.
Published: (2020-01-01)

Differential Methylation and Acetylation as the Epigenetic Basis of Resveratrol’s Anticancer Activity
by: Mohd Farhan, et al.
Published: (2019-02-01)

Loss of Deacetylation Enzymes Hdac6 and Sirt2 Promotes Acetylation of Cytoplasmic Tubulin, but Suppresses Axonemal Acetylation in Zebrafish Cilia
by: Paweł K. Łysyganicz, et al.
Published: (2021-06-01)

Activation of p21 by HDAC inhibitors requires acetylation of H2A.Z.
by: Luca Bellucci, et al.
Published: (2013-01-01)

Effect of the HDAC Inhibitor on Histone Acetylation and Methyltransferases in A2780 Ovarian Cancer Cells
by: Umamaheswari Natarajan, et al.
Published: (2021-05-01)

Hepatoblastomas in Oman : Unveiling success
by: Fatma Rabah, et al.
Published: (2015-02-01)

Prenatal Diagnosis of Congenital Hepatoblastoma
by: Jia-Yan Wang, et al.
Published: (2020-04-01)

Hepatoblastomas in Oman: Unveiling success
by: Fatma Rabah, et al.
Published: (2015-01-01)

Mesenchymal Hamartoma Mimicking Hepatoblastoma
by: A Bahador, et al.
Published: (2014-05-01)

Hepatoblastoma associated with trisomy 18
by: Naruhiko Murase, et al.
Published: (2020-01-01)

Unresectable hepatoblastoma: current perspectives
by: Trobaugh-Lotrario AD, et al.
Published: (2017-02-01)

A case of giant hepatoblastoma
by: MA Linjie, et al.
Published: (2016-11-01)

Extracorporal Shock Waves Activate Migration, Proliferation and Inflammatory Pathways in Fibroblasts and Keratinocytes, and Improve Wound Healing in an Open-Label, Single-Arm Study in Patients with Therapy-Refractory Chronic Leg Ulcers
by: Ilknur Aschermann, et al.
Published: (2017-02-01)

Resveratrol reverses morphine-induced neuroinflammation in morphine-tolerant rats by reversal HDAC1 expression
by: Ru-Yin Tsai, et al.
Published: (2016-06-01)

CITED1 Expression in Liver Development and Hepatoblastoma
by: Andrew J. Murphy, et al.
Published: (2012-12-01)

CHIC Risk Stratification System for Predicting the Survival of Children With Hepatoblastoma: Data From Children With Hepatoblastoma in China
by: Junting Huang, et al.
Published: (2020-11-01)

An ELISA method to assess HDAC inhibitor-induced alterations to P. falciparum histone lysine acetylation
by: Eva Hesping, et al.
Published: (2020-12-01)

Mixed hepatoblastoma and teratoma of the liver in a 3-year-old child: a unique combination and clinical challenge
by: Leuschner Ivo, et al.
Published: (2009-11-01)

Guidelines for the diagnosis and treatment of hepatoblastoma (2019)
by: Compilation and Examination Expert Group for Guidelines for the diagnosis and treatment of hepatoblastoma (2019)
Published: (2019-11-01)

The Role of MicroRNAs in Hepatoblastoma Tumors
by: Ion Cristóbal, et al.
Published: (2019-03-01)

Mechanisms of Anticancer Drug Resistance in Hepatoblastoma
by: Jose J. G. Marin, et al.
Published: (2019-03-01)